We report the pharmacological characterization and cytoprotective effe
ct of DY-9760e, 3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6- dim
ethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate,
a novel antagonist of calmodulin. DY-9760e inhibited calmodulin-depen
dent enzymes, including calmodulin-dependent phosphodiesterase and myo
sin light chain kinase with K-i values of 1.4, 12, 2.0, 3.8 and 133 mu
M, respectively. These antagonistic effects of DY-9760e were more pot
ent than those of W-7, -(6-aminohexyl)-5-chloro-1-naphthalenesulfonami
de, another calmodulin antagonist. This compound showed little or no e
ffect on calmodulin-independent enzymes, such as protein kinase A and
C and calpain I and II. Analysis of the hydrophobic interaction of DY-
9760e with calmodulin by using 2-p-toluidinylnaphthalene-6-sulfonate a
nd 9-anthroylcholine revealed that, like W-7, DY-9760e bound to the hy
drophobic regions of calmodulin. The [C-14]DY-9760e binding assay indi
cated that DY-9760e bound to calmodulin at one class of binding site.
Finally, DY-9760e substantially protected N1E-115 neuroblastoma cells
from cytotoxicity induced by the Ca2+ ionophore, A23187. These results
indicate that DY-9760e, a novel calmodulin antagonist, possesses a cy
toprotective action and suggest that calmodulin plays a critical role
in mediating some of the biochemical events leading to cell death foll
owing Ca2+ overload. (C) 1997 Elsevier Science B.V.